Cargando…
Research progress of interleukin-15 in cancer immunotherapy
Interleukin-15 (IL-15) is a cytokine that belongs to the interleukin-2 (IL-2) family and is essential for the development, proliferation, and activation of immune cells, including natural killer (NK) cells, T cells and B cells. Recent studies have revealed that interleukin-15 also plays a critical r...
Autores principales: | Cai, Menghan, Huang, Xuan, Huang, Xiting, Ju, Dianwen, Zhu, Yi Zhun, Ye, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213988/ https://www.ncbi.nlm.nih.gov/pubmed/37251333 http://dx.doi.org/10.3389/fphar.2023.1184703 |
Ejemplares similares
-
Progress of research on molecular targeted therapies for colorectal cancer
por: Huang, Shilin, et al.
Publicado: (2023) -
Interleukin 15 in Cell-Based Cancer Immunotherapy
por: Zhou, Yang, et al.
Publicado: (2022) -
A SIRPαFc Fusion Protein Conjugated With the Collagen-Binding Domain for Targeted Immunotherapy of Non-Small Cell Lung Cancer
por: Liu, Jiayang, et al.
Publicado: (2022) -
Rechallenge of immunotherapy beyond progression in patients with extensive-stage small-cell lung cancer
por: Li, Lingling, et al.
Publicado: (2022) -
Research progress of ginseng in the treatment of gastrointestinal cancers
por: Ni, Baoyi, et al.
Publicado: (2022)